XTalks

DECEMBER 4, 2024

Jupiter Neurosciences, a clinical-stage pharma company specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

World of DTC Marketing

DECEMBER 10, 2020

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. Drug wholesale list prices have doubled in recent years. The Pharma Spin.

Drugs 181

Drugs Research Manufacturing Development 181

XTalks

APRIL 2, 2024

There was also significant variability in emissions, up to five times, between pharma companies with comparable revenues. For example, Proctor & Gamble was found to emit almost five times more CO 2 e than Johnson & Johnson despite the two companies having similar revenue levels and producing similar lines of products.

Pharma Companies 102

Pharma Companies Packaging Packaging Production 102

World of DTC Marketing

JANUARY 4, 2022

Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug. Newly approved cancer drugs cost an average of $10,000 per month, with some as high as $30,000 per month. These cost estimates include cancer-attributable costs for medical services and oral prescription drugs. billion in 2015 and $208.9

Pharma Companies 273

Pharma Companies Drugs Medicine Research 273

Pharmaceutical Technology

SEPTEMBER 2, 2022

The rate of drug approvals could be on the rise. In a recent report, GlobalData revealed that the US Food and Drug Administration (FDA) approved 122 new drug applications (NDAs) and biologic license applications (BLAs) in 2021. There are many reasons why a company might prefer to keep commercialisation activities inhouse.

Drugs 130

Drugs Pharma Companies Medicine Production 130

Outsourcing Pharma

MAY 23, 2024

A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.

Pharma Companies 78

Pharma Companies Drugs Medicine Development 78

Pharmaceutical Technology

MARCH 31, 2023

On March 30, ViiV Healthcare and Medicines Patent Pool (MPP), announced sublicensing agreements with the pharma manufacturers Aurobindo , Cipla and Viatris to produce generic forms of the long-acting cabotegravir used as pre-exposure prophylaxis (PrEP) for HIV. This includes Apretude and the two oral drugs— Descovy and Truvada.

Medicine 130

Medicine Manufacturing Pharma Companies Licensing 130

World of DTC Marketing

JULY 27, 2022

anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. Pharma companies have very little control over patients’ prices for their Rxs. A federal appeals court rejected Pfizer’s challenge to a U.S.

Pharmacy 226

Pharmacy Generic Drugs Medicine Drugs 226

XTalks

MARCH 29, 2022

Jazz Pharmaceuticals has broken ground on a new $100 million manufacturing plant for cannabis-based medicines in the UK. According to a press release from Jazz Pharma, the plant has a planned opening date in 2024 and will welcome 100 new employees. Jazz is going green with its new facility in more than one way.

Medicine 111

Medicine Manufacturing Sales FDA Approval 111

Pharmaceutical Technology

FEBRUARY 24, 2023

The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

Pharmaceutical Technology

AUGUST 12, 2022

In principle, the deal could create new opportunities for British pharma companies – not least the chance to work under a more supportive regulatory framework. Among the negative effects that have been reported are supply chain disruptions, skills shortages, issues around market authorisation, and added costs for pharma CMOs.

Medicine 290

Medicine Production Generic Drugs Regulation 290

pharmaphorum

NOVEMBER 16, 2022

The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharma companies for their efforts to improve delivery of medicines to lower income countries – sees GSK retain the number one position, newly joined by Johnson & Johnson in second and AstraZeneca in third. Jayasree Iyer.

Medicine 105

Medicine Production Pharma Companies Licensing 105

pharmaphorum

JULY 11, 2024

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.Lawmakers unanimously passed the Affordable Prescriptions for Patients Act of 2023 (S-150), which is part of a lengthening list of measures being taken by Congress to curb the (..)

Pharma Companies 122

Pharma Companies Medicine Drugs 122

pharmaphorum

AUGUST 5, 2020

The UK government has asked pharma companies to build a six-week stockpile of drugs and find alternative shipping routes to the congested Dover-Calais crossing as the country heads for Brexit at the end of the year. The post Fearing Brexit chaos, UK asks pharma to build six-week drug stockpile appeared first on.

Drugs 111

Drugs Pharma Companies Medicine 111

pharmaphorum

JULY 8, 2022

The pharmaceutical industry is increasingly relying on artificial intelligence to power its drug discovery and development efforts, and its spend in this area has created a multibillion-dollar market for AI technologies. As it stands, the time needed for a drug to reach the market ranges from 12 to 18 years, with an average cost of about $2.6

Drugs 131

Drugs Clinical Development Marketing Genomics 131

pharmaphorum

MAY 4, 2022

Testing drug compounds on a chip designed to mimic human organs sounds closer to science fiction than reality, yet the technology already exists and is already being put to use. The limits of animal models in drug discovery are well known. The limits of animal models in drug discovery are well known. Beyond testing.

Drugs 143

Drugs Licensing Licensing Pharma Companies 143

Pharmaceutical Technology

MARCH 22, 2023

In recent times, suppliers have also chosen other systems that rely on blockchain and sensors to track drug supply and reduce the influx of counterfeit drugs. The US Food and Drug Administration (FDA) has provided guidance for the use of RFID in the drug supply chain and to standardise the data format.

Production 264

Production Pharma Production Pharma Companies Drugs 264

World of DTC Marketing

SEPTEMBER 24, 2021

This drug was never about patients; it was about a company whose ego got too big and needed a savior in the form of a medicine that could bring in hundreds of millions of dollars. They had a new MS drug that was the talk of the industry and an exciting pipeline. Can Biogen regain its momentum?

Drugs 222

Drugs Pharma Companies Doctors Doctor 222

World of DTC Marketing

APRIL 21, 2021

” J&J has had problems in the past, but they’re trying to be an ethical and responsible pharma company. Gilead became infamous a few years ago for charging $84,000 per course of treatment for Sovaldi, a “groundbreaking” hepatitis-C drug. PBMs too are making a fortune.

Vaccine 273

Vaccine Vaccination Pharmacy Pharma Companies 273

pharmaphorum

JANUARY 12, 2023

Bayer has signed an agreement with Google aimed at using high-level processing power to handle quantum chemistry calculations used to predict the chemical and physical properties of drug molecules at the atomic scale. The post Bayer taps Google’s quantum power for drug discovery appeared first on. Image source: Google.

Drugs 122

Drugs Protein Pharma Companies Sales 122

pharmaphorum

APRIL 19, 2021

But it has also faced criticism from pharma companies that say it undervalues medicines – patients in the country were denied access to the expensive cystic fibrosis drug Orkambi for four years because of a pricing row with NICE and the NHS.

Medicine 88

Medicine Pharma Companies Genomics Genome 88

pharmaphorum

MAY 20, 2022

Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer medicines in low- and lower-middle-income countries (LLMICs). It is taking a broader approach, making sure patients living with cancer “receive the medicines they need at the right time,” he said.

Drugs 111

Drugs Medicine Licensing Licensing 111

Pharmaceutical Technology

JUNE 14, 2023

A GlobalData report which analyzes trends in new drug approvals [i] shows that small molecule approvals have now been surpassed (in 2022) by biologics. Biologics form 51% of the current global drugs pipeline (highest stage of development as pipeline) according to GlobalData’s Drugs database (as of February 7, 2023).

Contract Packaging 130

Contract Packaging Packaging Packaging Development 130

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Development Genetic Disease 225

Pharmaceutical Technology

JULY 14, 2022

Regulatory decisions have a ripple effect, first affecting the pharma sponsors, and then the companies tasked to manufacture the drug. Pharmaceutical Technology looks at drugs and biologics with recent regulatory verdicts that will likely impact manufacturing volumes.

Manufacturing 130

Manufacturing Drugs Vaccine Vaccination 130

pharmaphorum

AUGUST 4, 2020

Sanofi has been placed under formal investigation in France for possible charges including manslaughter relating to the epilepsy drug Depakine, following the deaths of four babies whose mothers took the drug. The drug is widely prescribed under different names as a treatment for epilepsy and other forms of seizure.

Drugs 105

Drugs Pharma Companies Medicine Trials 105

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Development Insulin 94

pharmaphorum

FEBRUARY 16, 2021

Medical charity Alzheimer’s Research UK has teamed up with artificial intelligence specialist Exscientia to find new drug treatments for the devastating neurodegenerative disease. . The post Alzheimer’s Research UK starts AI-based drug hunt with Exscientia appeared first on.

Research 119

Research Drugs Protein Development 119

pharmaphorum

JANUARY 7, 2022

If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9 Shortly after Amgen unveiled its $1.9

Drugs 110

Drugs Pharma Companies Medicine Licensing 110

Camargo

NOVEMBER 11, 2020

When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product.

Development 242

Development Bioequivalency Generic Drugs Production 242

pharmaphorum

NOVEMBER 3, 2022

Consumer and health organisations in the UK have written to the Trade Secretary Kemi Badenoch, saying a leaked chapter of the proposed UK-India free trade agreement (FTA) could raise the price of medicines used by the NHS. “India…supplies our NHS with 25% of all the medicines used to treat patients here in the UK,” they continue.

Medicine 85

Medicine Pharma Companies Sales Drugs 85

World of DTC Marketing

APRIL 14, 2021

BMS believes they price our medicines based on the value they deliver,” but physicians say the price is too high. One of the biggest problems with a system that directs medical research towards profits rather than needs is that R&D funding is channelled to those products that can make pharma companies the most money.

Pharma Companies 147

Pharma Companies Vaccine Vaccination Sales 147

Delveinsight

SEPTEMBER 24, 2021

Pharma companies such as Calliditas Therapeutics AB, Chinook Therapeutics, Inc., Some of the drugs in the pipeline include Iptacopan (Novartis), Narsoplimab (Omeros Corporation), Nefecon (Calliditas Therapeutics), Atrasentan (Chinook Therapeutics), Sparsentan (Travere Therapeutics, Inc.), IgA Nephropathy Pipeline Drugs.

Pharma Companies 77

Pharma Companies Marketing Protein Drugs 77

World of DTC Marketing

MARCH 11, 2022

consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. consumers say they trust pharma companies more than they did before the COVID-19 pandemic, according to Accenture’s 2021 survey. What does this mean for DTC and HCP marketing?

Pharma Companies 212

Pharma Companies Vaccine Vaccination Drugs 212

pharmaphorum

FEBRUARY 26, 2021

UCB and Microsoft have announced a multi-year strategic collaboration to advance the digitalisation of the Belgian pharma company and accelerate its research efforts. The companies have already been working together on the COVID Moonshot Project, which aimed to create an orally available antiviral to combat the SARS-CoV-2 coronavirus.

Drugs 97

Drugs Medicine Pharma Companies Clinical Development 97

XTalks

JANUARY 20, 2025

Key benefits included the addition of Celgenes blockbuster drug Revlimid (lenalidomide), a cornerstone of its oncology portfolio, and access to innovative CAR-T therapies such as Abecma (idecabtagene vicleucel). Actavis Acquisition of Allergan Deal value : $70.5

Marketing 104

Marketing Botox Life Science Pharma Companies 104

pharmaphorum

AUGUST 9, 2022

AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential to use tissue samples to create precision medicine for specific patient groups. An area that offers hope to accelerate an understanding of cancer and speed up drug development is artificial intelligence.

Drugs 111

Drugs Doctors Doctor Pharma Companies 111